Abstract
ABSTRACTWe consider two treatment comparison in a clinical trial setup where the responses from one treatment are a priori known for a fixed number of individuals and patients are allocated in a groupsequential way for the other treatment using inverse sampling. We consider the odds ratio as the measure of treatment difference at the end of each group, where for the calculation of odds ratios we consider the full data on one treatment, which are a priori known, and the available data on the other treatment up to that point of time. We have calculated the optimal number of index subjects for inverse sampling and examine the effects of different type I and type II error spending functions on group sequential testing in this context. The methodology is illustrated by using a real data set.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
